Clinical management of selected oral fungal and viral infections during HIV-disease. (Q33945706)

30 July 2017

1 reference

title

Clinical management of selected oral fungal and viral infections during HIV-disease. (English)

1 reference

30 July 2017

Reichart PA

1

1 reference

30 July 2017

publication date

1 October 1999

1 reference

International Dental Journal

30 July 2017

published in

1 reference

30 July 2017

volume

49

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

251-259

1 reference

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Oral mycoses in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

HIV-associated oral lesions; immunologic, virologic and salivary parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Oral candidosis. Clinical, historical, and therapeutic features of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Treatment of oral candidiasis in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Future directions of antifungal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Laboratory evaluation of antifungal agents: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Antifungal therapy in oropharyngeal mycotic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Antifungal susceptibility testing: technical advances and potential clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Refractory mucosal candidiasis in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Epstein-Barr virus infection and expression in oral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Oral hairy leukoplakia: observations in 95 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia. Clinical results in nine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Famciclovir: review of clinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Sorivudine: a promising drug for the treatment of varicella-zoster virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

Emerging international consensus for use of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-595X.1999.TB00795.X

10.1002/J.1875-595X.1999.TB00795.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference